Skip to main content
Caplight Logo









Jupiter Bioventures

Jupiter Bioventures

Private
—Healthcare & Life Scienceshttps://jupiter.bio

Last Round

Seed

Nov 19, 2024

Total Funding Raised

$70M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Jupiter Bioventures operates in Healthcare & Life Sciences. Its latest recorded funding round was a Seed round in November 2024.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Jupiter Bioventures Comparables

Compare Jupiter Bioventures with similar companies based on industry and business-model similarity.

Jupiter Bioventures comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xerient Pharma
36%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Jupiter Bioventures Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 19, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Jupiter Bioventures Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors increased 138% MoM, reaching 4.1K.

  • Apr 23, 2026

    Monthly visitors increased 53% MoM to 2.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Jupiter Bioventures Filings

Explore SEC and related filing metadata, where available.

Jupiter Bioventures filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Jupiter Bioventures's valuation, stock price, and market status.

Is Jupiter Bioventures a public or private company?

Jupiter Bioventures is a private company.

What is the current stock price of Jupiter Bioventures?

Jupiter Bioventures is a private company, so its shares have no public market price. Caplight tracks Jupiter Bioventures's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Jupiter Bioventures worth (valuation)?

Valuation information for Jupiter Bioventures is not publicly available.

Can I buy Jupiter Bioventures stock?

Jupiter Bioventures shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Jupiter Bioventures's last funding round?

Jupiter Bioventures's most recent funding round was Seed on November 19, 2024.

Who are the main investors in Jupiter Bioventures?

Key investors in Jupiter Bioventures include Mission BioCapital.

Will Jupiter Bioventures IPO soon?

No public IPO plans have been announced for Jupiter Bioventures.

How can I track Jupiter Bioventures secondary market activity?

Caplight tracks bids, offers, and trades in Jupiter Bioventures's shares on secondary markets.

Firmographic Details

Headquarters—
Employee Range12
Year FoundedN/A
Last FundingNov 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?